Clinical Trial Update: A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions. [Phase 1]

View source ↗

Summary

A Phase 1 bioavailability study of nilotinib in healthy adult participants under fasted conditions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• Tasigna (nilotinib)

Snippet

Sponsor: Xspray Pharma AB | Conditions: Cancer | Phase 1 | Status: COMPLETED